Technical Analysis for CNST - Constellation Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 37.39 -0.35% -0.13
CNST closed down 0.35 percent on Friday, June 5, 2020, on 87 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical CNST trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Shooting Star Candlestick Bearish -0.35%
Lizard Bearish Bearish Day Trade Setup -0.35%
Doji - Bearish? Reversal -0.35%
Outside Day Range Expansion -0.35%
Wide Bands Range Expansion -0.35%
Wide Bands Range Expansion -1.27%
Crossed Above 50 DMA Bullish -1.50%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Constellation Pharmaceuticals, Inc. is a United States-based company, which discovers and develops small molecule therapeutics for the treatment of cancer, inflammatory/immunologic disorders and other diseases. The Company has two clinical-stage oncology development programs: the first program is evaluating a compound, CPI-0610, and the other program is evaluating a compound, CPI-1205. CPI-0610 is a small molecule that inhibits the binding of bromodomain and extra terminal (BET) proteins to chromatin. CPI-1205 is a small molecule that inhibits an enzyme, Enhancer of Zeste Homolog 2 (EZH2). It is in a Phase I clinical study of CPI-0610 in patients with progressive lymphoma; a Phase I clinical study of CPI-0610 in patients with acute leukemia, myelodysplastic syndrome or myelodysplastic/myeloproliferative neoplasms; a Phase I clinical study of CPI-0610 in patients with previously treated multiple myeloma, and a Phase 1 clinical study of CPI-1205 in patients with lymphoma.
Cancer Diseases Treatment Of Cancer Lymphoma Multiple Myeloma Myelodysplastic Syndrome Acute Leukemia Ezh2 Myeloproliferative Neoplasm

Is CNST a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 59.4899
52 Week Low 6.01
Average Volume 430,344
200-Day Moving Average 29.62
50-Day Moving Average 36.88
20-Day Moving Average 39.59
10-Day Moving Average 36.12
Average True Range 2.97
ADX 16.54
+DI 22.43
-DI 23.15
Chandelier Exit (Long, 3 ATRs ) 41.98
Chandelier Exit (Short, 3 ATRs ) 41.07
Upper Bollinger Band 49.94
Lower Bollinger Band 29.23
Percent B (%b) 0.39
BandWidth 52.32
MACD Line -0.48
MACD Signal Line -0.22
MACD Histogram -0.2593
Fundamentals Value
Market Cap 66.34 Million
Num Shares 1.77 Million
EPS -49.87
Price-to-Earnings (P/E) Ratio -0.75
Price-to-Sales 0.00
Price-to-Book 0.23
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.25
Resistance 3 (R3) 41.34 40.16 40.60
Resistance 2 (R2) 40.16 39.17 40.11 40.39
Resistance 1 (R1) 38.77 38.57 38.18 38.68 40.17
Pivot Point 37.59 37.59 37.29 37.54 37.59
Support 1 (S1) 36.20 36.60 35.61 36.11 34.61
Support 2 (S2) 35.02 36.00 34.97 34.39
Support 3 (S3) 33.63 35.02 34.18
Support 4 (S4) 33.54